Vantage Biosciences
Vantage Biosciences is a developer of an oral therapy designed for diabetic eye diseases.
Vantage Biosciences is a business in biotechnology, health care, product research, therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2023.
Vantage Biosciences is positioned in biotechnology, health care, product research, therapeutics, a segment that rewards a clear, focused offering.
The business is associated with Europe, Middle East, and Africa (EMEA).
Directory data places it at the Seed stage.
Recorded headcount: c_00001_00010 employees.
| Sector | Biotechnology, Health Care, Product Research, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2023 |
| Employees | c_00001_00010 |
| Stage | seed |
Website: www.vantage-biosciences.com
Browse related
Sign in to view the contact information we hold for Vantage Biosciences.
Create a free account
Create a free account